SSI research ‘well above world standard’
in Ageing, Clinical Trials, Dry eye and blepharitis, Education, Events, Fundraising, Glaucoma, History and People, Macular Degeneration, Neuroscience, News, Ocular Surface Disease, Paediatrics, Registries, Retinal dystrophies
4 Dec 2015
The Australian Research Council (ARC) has released its Excellence in Research for Australia (ERA) results, awarding the Save Sight Institute’s Discipline of Clinical Ophthalmology at The University of Sydney a rating of five (5), the highest possible score in its five tier ratings system.
This outcome confirms that research at Save Sight Institute continues to be well above world standard.
According to Professor Peter McCluskey, Director of Save Sight Institute, “We are exceptionally proud to again be awarded the highest possible rating in the Australian Research Council’s results. Our results are consistently excellent, being awarded the highest possible score in all previous ERA reports.”
The ERA rating system is a quality assurance mechanism for Australia’s universities, and is the primary mechanism to report on comparative research performance to investors and donors. Its evaluation framework gives government, industry, business and the community assurance of the standards of research underway in our higher education institutions, with particular consideration of quality, activity, application and recognition.
The ERA results provide a national stocktake of disciplines, identifying strengths and areas where there is opportunity for further development, and allows for comparisons of Australia’s research nationally and internationally.
“Our clinical and laboratory team set the benchmark for ophthalmology research in Australia and internationally” said Head of Discipline, Professor John Grigg “and we are making excellent progress. I would like to sincerely thank our supporters and donors for enabling us continue doing this important work which aims to improve the quality of life for people affected by eye disease, now and in the future.”